Administration of exogenous endothelin-1 (ET-1) has been shown to stimulate neointimal hyperplasia following arterial balloon angioplasty (BA). However, the specific effects of ET-1 on the cellular and extracellular matrix response of the vessel wall after balloon injury and the persistence of these ET-1 effects have not been studied. The objectives of this study were to determine the acute (1 week) and long term (10 weeks) effects of administering exogenous ET-1 after arterial BA on neointimal hyperplasia, collagen synthesis and content, cellular proliferation, and ET and ET receptor expression. Thirty-one rabbits were randomized to receive subcutaneous ET-1 A B
Introduction
ET-1 infusion increases intimal hyperplasia after balloon injury in the rat model [5] [6] [7] . However, it is not known A number of cytokines and growth factors have been whether the intimal thickening is due to a cellular and / or implicated in the pathogenesis of the arterial response to an extracellular matrix effect. Moreover, the persistence of balloon angioplasty (BA) injury. Endothelin-1 (ET-1) is a this effect on intimal hyperplasia after withdrawal of 21 amino acid peptide that stimulates both cell proliferexogenous ET-1 is unknown. The objectives of this study ation [1] [2] [3] and collagen synthesis in cultured smooth were to characterize the mechanisms of ET-1 stimulated muscle cells (SMC) [4] . In vivo studies have shown that intimal hyperplasia by: (1) identifying the early and late in vivo effects of a brief (1 week) ET-1 administration on intimal hyperplasia, collagen metabolism and cell proliferation; and (2) assessing the effects of exogenous ET-1 on the expression of molecular components of the intrinsic ET-1 system in the vessel wall, namely preproET-1 and the bromodeoxyuridine (BrdU, Sigma), a thymidine analog, two receptor subtypes ET and ET .
was injected subcutaneously at 24 and 12 h prior to A B sacrifice to assess cell proliferation. A monoclonal antiBrdU antibody (Dako) was used as the primary antibody 2. Materials and methods
(1:50 dilution), as previously described [8] . Totals labeled cells were counted under 403 magnification.
Model
The animal experiments were performed in accordance 2.5. Measurement of preproendothelin-1 mRNA by with guidelines set out by the University of Toronto and reverse transcription-polymerase chain reaction (RTapproved by the St. Michael's Hospital Animal Care PCR) Committee. We used a double-balloon normolipemic injury model in 34 male New Zealand White rabbits weighing RNA was extracted from the proximal segment of the 3.6-3.8 kg as previously described [8] . The initial 3 cm of injured left iliac artery using a standard guanidinium both common iliac arteries immediately distal to the aortic isothiocyanate phenol-chloroform extraction procedure as bifurcation underwent dilation with a 30 mm length, 3.0 previously described [9] . Two micrograms of the total mm diameter BA catheter. After recovery, the rabbits were RNA was reverse transcribed using Moloney Murine fed regular rabbit chow and water ad libitum. BA of both Leukemia Virus Reverse Transcriptase (MMLV-RT, Life iliac arteries (injury [2) was repeated 3 weeks later.
Technologies) and random primers in a total volume of 20 Immediately after injury [2, a time-release pellet (Innovaml. Five microlitres of the reverse transcription mixture tive Research of America, Sarasota, FL), containing either was used for the amplification of preproendothelin-1 ET-1 (500 pM / kg / day for 7 days) or placebo, was (ppET-1) and glyceraldehyde 3-phosphate dehydrogenase implanted subcutaneously. This dose was based on a (GAPDH) in a polymerase chain reaction (PCR) using previously published rat data which showed maximal either 90 or 50 pM each of rabbit ppET-1 or human effects on intimal hyperplasia without affecting blood GAPDH sense and antisense primers, respectively. The pressure [5] . In selected animals, blood samples were taken ppET-1 primers were designed to generate a 506 bp immediately and at 1, 2, 4, 7 and 14 days after pellet fragment while the GAPDH primers generated a 343 bp placement for measurement of plasma ET-1 levels. Anifragment by PCR. The PCR procedure was carried out mals were killed with a fatal injection of sodium penwith an initial denaturation step for 5 min at 948C followed tobarbital at either 1 week or 10 weeks after the second by 40 cycles for ppET-1 or 25 cycles for GAPDH of 1 min injury. The iliac arteries were then isolated and removed.
denaturation at 948C, 1 min annealing at 608C and 1 min The proximal 1.5 cm segments of the iliac arteries were extension at 728C. The intensity of ppET-1 bands was used for the collagen and mRNA studies. The distal 1.5 cm assessed relative to their respective GAPDH band density. segments were fixed in 4% paraformaldehyde and used for histology. receptor competitor (448 bp) were reverse transcribed. The Collagen synthesis and content measurements were reaction products were electrophoresed on a vertical Novex performed in the proximal segment of the injured right system, and stained with ethidium bromide for visualiza- 14 iliac artery using a C-hydroxyproline assay, as previoustion under high-energy ultra-violet radiation. The intensity ly described [8] . Results of collagen synthesis and content of the wild-type and competitor bands at each dilution of were expressed per arterial segment. In 10 animals that were sacrificed at 1 week, 300 mg mRNA present in each sample was then calculated from the graph by intrapolating the log [competitor cRNA] blood pressure compared to placebo treated animals or where the log ratio (wild-type / competitor) is zero (i.e. compared to the blood pressure measurements recorded at molar equivalence of wild-type and competitor cRNA).
ET and ET receptor
the time of the angioplasty procedure (data not shown). This assay has been validated in several species, including There were no baseline differences in plasma ET-1 levels rabbits [10] .
before the angioplasty between the two groups (ET-1: 2.2460.08 fM / ml, placebo: 2.1860.08 fM / ml, P5ns).
The peak plasma ET-1 levels occurred during the first 4 2.6.2. Immunostaining with confocal microscopy days after the balloon injury with a return to baseline ET-1 Paraformalin fixed paraffin-embedded serial sections (6 levels at 7 days. Peak plasma ET-1 levels were modestly mm thickness) were deparaffinized and incubated for 30 increased in ET-1 treated animals compared to placebo min in 0.1% Saponin / phosphate buffered saline (PBS) / 1% treated animals (3. [54-279] mg hydroxyproline / arterial segment, P,0.01) ( Table 1) . Placebo treated animals demonstrated a threefold increase in collagen content at 10 weeks post angiop-3. Results lasty compared to 1 week period, while no differences occurred in ET-1 treated animals over the same time. At 10 3.1. In vivo studies weeks, there were also no significant differences in either collagen content or synthesis between ET-1 treated and A total of 34 rabbits were used in the study. Three placebo treated animals. perioperative deaths occurred from surgical complications at the time of the second angioplasty (one placebo, two ET-1). Twenty animals (five animals / treatment group / 3.4. Proliferation indices and cell density time point) were initially included in the histology, collagen and mRNA assays. Eleven animals (eight ET-1, three There were significant increases in both intimal and placebo) were later included for the determination of ET-1 medial cell proliferation in ET-1 treated animals (n57 plasma levels and additional RNA studies. In animals arteries) compared with placebo treated animals (n59 sacrificed at 1 week following the second injury and arteries) at 1 week (Fig. 2) . The ET-1 treated animals placement of the ET-1 pellet, there were no differences in demonstrated a significantly reduced intimal cell density at ET-1 and placebo treated groups (data not shown).
PreproET-1 mRNA levels
PreproET-1 mRNA was detectable in the vessel wall at 4. Discussion 1 week in both placebo and ET-1 treated rabbits (Fig. 3) . At 10 weeks, ET-1 expression was barely detectable in Endothelin has been implicated in the pathogenesis of either ET-1 or placebo treated rabbits.
restenosis after balloon injury. Fig. 4) . By 10 weeks, there was a restricted to measurements of intimal areas and have not marked and significant downregulation (approximately addressed the mechanisms by which ET-1 causes its 90%) of both ET and ET receptor mRNA levels in both effects. Therefore, we performed this detailed study of the A B groups compared to 1 week. There were no significant cellular and extracellular matrix (ECM) responses to ET-1 differences at 10 weeks between ET-1 treated and placebo administration in a rabbit iliac artery injury model. treated animals for ET mRNA levels although ET The main finding of our study is that exogenous ET-1 A B receptors mRNA levels were still two-fold higher in ET-1 promotes intimal thickening by increased collagen syntreated animals (P,0.05).
thesis and content and to a lesser degree by stimulation of cell proliferation. The ECM effects appeared to predomireceptor expression at 1 week in ET-1 treated animals, nate since collagen synthesis increased ten-fold, while cell these effects did not persist. The placebo treated animals, proliferation demonstrated a more modest two-fold inwhich are also exposed to endogenously released growth crease in ET-1 treated rabbits at 1 week. Furthermore, factors and cytokines, demonstrated a similar but someintimal cell density at 1 week post balloon injury was what delayed healing pattern as the ET-1 supplemented significantly decreased in the ET-1 treated group, suganimals with eventual 'catch up' by 10 weeks after the gesting a disproportionate increase in ECM accumulation procedure. relative to the increase in intimal cells. The second Our data support ET-1 as an important mediator of ECM significant finding was that these ET-1 effects were response after balloon injury. This particular function of mediated by increased expression of both ET and ET ET-1 is consistent with its ECM stimulatory effects on . Several diseases have been identified that are associated with enhanced endothelin activity including scleroderma [20] , pulmonary hypertension [21, 22] , pul- Table 2 monary fibrosis [23] , nephroangiosclerosis [24] , hepatic ET and ET receptor mRNA expression A B fibrosis [25] , and cardiac hypertrophy [26, 27] . Similar to the lung increased in parallel with an increase in total A B collagen accumulation [22] . ET-1 also plays an important ranging from potent stimulation [4, 32, 33 ] to no effect role on the progression of experimental glomerulonephritis [34, 35] . [29] . Exogenous ET-1 stimulates mesangial synthesis of ECM components such as type I, III and IV collagen, 4.
ET and ET expression after exogenous ET-1 and A B
laminin, fibronectin, and tenascin [30, 31] . While a conballoon injury sistent relationship between ET-1 and enhanced ECM synthesis has been reported, several studies have shown
The biological effects of ETs are mediated by two rather variable effects of ET-1 on SMC proliferation, different receptor subtypes, ET and ET [35] [36] [37] . In the formation (by up to 150%) at 14 days in a rat carotid sponses that contributes to intimal hyperplasia after bal-
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